Nofinity Logo

Latest Analyses(7)

Bitcoin: Now It's Getting Really Critical! NVIDIA Scandal = Crisis?
2 min read

Bitcoin: Now It's Getting Really Critical! NVIDIA Scandal = Crisis?

Bitcoin: Critical Situation and NVIDIA Scandal Weigh on Markets

The Bitcoin price struggles around the crucial $74,000–$76,000 mark, pressured by a downtrend and weak spot demand. The current correction is amplified by an NVIDIA scandal (CEO's affair with a suspected Chinese spy) and the shaky AI bubble. Hedge funds are selling heavily, and leveraged positions are being liquidated. However, the analyst sees long-term opportunities and is buying dips strategically.

Current Market Situation

  • Bitcoin Price: Hovering near $74,000, risk of a drop to $65,000–$70,000.
  • Altcoins: Sharp losses (e.g., Ethereum at $2,100, XRP falling).
  • Stock Market: S&P 500 and Nasdaq under pressure from NVIDIA sell-offs.

NVIDIA Scandal and AI Trade

  • Trigger: CEO Jensen Huang admits affair with a Chinese woman classified as a spy.
  • Consequences: NVIDIA stock drops 5%, AI stocks overall under pressure, but the company's cash flows remain strong.
  • Assessment: Analyst sees an emotional reaction, not a fundamental crisis. AI chips are still in high demand long-term.

Warnings and Opportunities

  • Risks: Foreign investors are buying US stocks aggressively, leveraged ETFs increase volatility. Inflation nearing 4% could fuel rate hike fears.
  • Opportunities: Historical data shows that sharp sell-offs (daily losses > 4%) often lead to recoveries within 3 months. Analyst is positioning with cash reserves for lower prices (target: $50,000–$65,000).

Portfolio Update

  • Stocks: 20% invested (50% in AI supply chain), 25% down.
  • Cryptocurrencies: High cash ratio, buy orders placed at $70,000 and $65,000.
  • Strategy: No full investment in uncertain market, but strategic dip buying.
Future Outlook
  • Positive: A peace deal with Iran could trigger bullish momentum.
  • Negative: Without stock market recovery, Bitcoin risks falling below $70,000.
  • Focus: Next corporate earnings (e.g., CoreWeave) and inflation data in November.

Conclusion: The market remains nervous, but long-term investors should use the correction as an entry opportunity – not buying blindly, but setting strategic limits.

3 Stocks I Own - Research Platform Overview!
3 min read

3 Stocks I Own - Research Platform Overview!

Platform Overview

The creator, a seasoned value investor with almost 25 years of experience, a former accounting & finance professor, and author of the Value Investing Handbook, presents his Research Platform. The goal is to build a 'Value Investment Pillar' focused on risk mitigation and a margin of safety.

Core Philosophy: Value Investing
  • Focus on Businesses, Not Stock Prices: It's not about speculating on price movements, but about buying entire businesses at a fair price.
  • The 'Net Nets' Principle: The goal is to find companies where the cash and market capitalization are so close that you effectively get the operating business 'for free.'
  • Margin of Safety: Volatility is not feared but seen as the value investor's friend, providing opportunities to buy more of a solid business at a discount.
The Three Stocks in Focus (Portfolio Examples)

The creator highlights three specific stocks to illustrate his Value Investing methodology:

  • First Pacific: An Asia-Pacific holding company. It offers a dividend yield of roughly 5% and benefits from the underlying growth of its businesses (food, infrastructure, telecom). You are buying into the development of Southeast Asia.
  • FERV (Ferve): A US-based value play. The stock crashed, bringing it into a single-digit P/E ratio, a classic setup for a turnaround/value pick with strong buyback programs.
  • Mosaic: A cyclical fertilizer company. The value of the potash mine and physical assets alone already covers the entire market capitalization. This provides a massive built-in margin of safety.
The Three Portfolios Strategy

The platform structures its recommendations into three distinct portfolios:

PortfolioNumber of PositionsExpected ReturnDescription
Diversified Portfolio~15 positions10%+Broad diversification, moderate risks, regular re-evaluation.
Model Portfolio7 positions~15%The core strategy. Stricter selection, higher expected return, tightly aligned with Value Investing rules.
Personal PortfolioFlexibleBest availableThe 'Charlie Munger / Warren Buffett' approach: Simply buy the best businesses you can find.
Performance & Target Audience
  • Performance: The Model Portfolio has achieved a ~12-15% annual return over eight years. The focus is on absolute fundamental growth driven by business performance, not just beating a specific index.
  • Pricing: $499 per year (21-day money-back guarantee, price increasing in January 2027). For the average member (portfolio size ranging from $100k to several million), this is viewed as a high-quality educational tool that pays for itself quickly.
  • Target Audience: The platform is tailored for the 'top 1-2%' of investors who understand that risk-conscious, ownership-based wealth building requires deep, fundamental research.
Conclusion

An invitation to trial the platform via the weekly email updates (10-15 minute read) and see if this margin-of-safety, value-driven investing approach aligns with your long-term financial goals.

Americans Will Buy Anthropic Whether They Want to Or Not | David Shapiro
3 min read

Americans Will Buy Anthropic Whether They Want to Or Not | David Shapiro

Overview of Anthropic's IPO
  • Anthropic is approaching its IPO and could be included in the Nasdaq 100 due to its size, similar to SpaceX. This would trigger forced buying by passive funds like QQQ, significantly boosting liquidity.
  • S&P 500 has excluded SpaceX, limiting the impact on passive investors. The Nasdaq 100 encourages accelerated inclusion to incentivize listings.
Liquidity and Lock-up Periods
  • Venture capital investors (e.g., Sequoia, a16z) typically face a 180-day lock-up after IPO. Some large holders may have extended lock-ups.
  • After lock-up expiration, increased volatility is expected as early investors seek DPI (Distribution to Paid-In Capital).
  • Additional liquidity from index inclusion and greenshoe options is anticipated.
Concentration in Venture Capital
  • Top names like Anthropic, OpenAI, SpaceX, and DataBricks dominate private indices (up to 20 % weight).
  • This concentration mirrors the Mag 7 in public markets. Without caps, AI-related companies would constitute 65–70 % of indices.
  • Alpha in late-stage investing (e.g., Series D) often derives from beta (market returns), underlining the need for low fees in passive strategies.
Future of Private Markets and Indices
  • OpenVC and the NYSE offer indices (e.g., NYSE Unicorn Index) for private companies, based on secondary market data.
  • Valuations are updated daily using real transactions, preventing zombie valuations.
  • Open-end ETFs for private markets are in development, but illiquidity requires innovative solutions (e.g., companion assets).
Anthropic vs. OpenAI Comparison
  • Both frequently swap places in valuation. Anthropic is expected to IPO before OpenAI, serving as a bellwether for OpenAI's strategy.
  • OpenAI has a valuation of about $1 trillion (per OpenVC index) after its latest fundraise – below the targeted $1–1.25 trillion.
  • Commoditization (falling token costs) and open-source competition (especially from China) pose long-term profitability risks.
Bull vs. Bear Case for AI
  • Bull case: A 25 % productivity boost per US worker could lead to a TAM of $5–10 trillion, justifying valuations of $1.5–2 trillion for leaders.
  • Bear case: Falling token costs and margin compression could undermine profitability even with high revenues.
Relevance for Investors
  • Private markets are less volatile than public ones, but price declines occur with a lag.
  • Anthropic has been resilient during the recent AI selloff but now trades in the $1.3–1.5 trillion range.
  • Stripe and DataBricks are other potential IPO candidates, with Stripe likely staying private.
How To Protect Your Eyes From Screens (5 Tips)
3 min read

How To Protect Your Eyes From Screens (5 Tips)

Introduction – Why Eye Health Is More Important Than Eyesight
  • Many people underestimate the risk of dry eyes and damaged tear film due to prolonged screen use.
  • A routine eye exam revealed a serious issue: blocked glands in the eyelids can lead to blindness if left untreated.
Step 1: Get a Clinical Baseline
  • 20/20 vision does not mean your eyes are healthy.
  • A detailed check (including cornea imaging) provides a baseline before symptoms appear.
Step 2: Treat the Eyelids, Not Just the Eyeballs
  • The eyelids contain Meibomian glands that produce oil to keep tears on the eye.
  • These glands easily clog due to medications (e.g., SSRIs, birth control pills), retinoids, and other factors.
  • Eye drops alone are not enough – the lids must be clean.
Step 3: Daily Warm Compress
  • Morning and evening: Clean lid margins with hypochlorous acid, then apply a heated eye mask (108–110°F / 42–43°C, max 113°F / 45°C) for 10 minutes.
  • Heat liquefies thickened oil (like toothpaste) and restores the natural oil layer.
  • Safety test: Temperature should feel comfortable on the back of your hand.
Step 4: Take Blink Breaks (20-20-20 Rule)
  • While staring at screens, your brain forgets to blink → eyes dry out.
  • Every 20 minutes, look 20 feet away for 20 seconds and blink 5 times.
  • This relaxes eye muscles and spreads lid oil across the cornea.
Step 5: Targeted Nutrition & Modern Technology
  • Omega-3 fatty acids and lutein support tear quality and retinal tissue.
  • The video features a photobiomodulation mask (red light therapy) that boosts cellular energy and provides instant hydration.
  • This technology is being tested in clinical studies and is not yet widely available.
Recap – The Daily Eye Protocol:
  1. ✔️ Get an eye exam (including lid check)
  2. ✔️ Clean eyelids with hypochlorous acid
  3. ✔️ Use daily warm compress for oil glands
  4. ✔️ Practice 20-20-20 blink breaks
  5. ✔️ Nourish from inside and out (omega-3, lutein, possibly light therapy)

Bottom line: These five simple habits turn eye care from an afterthought into a functional daily protocol – because you only get one pair of eyes.

I Turned Claude Fable 5.2 Into a 24/7 Stock Trader
2 min read

I Turned Claude Fable 5.2 Into a 24/7 Stock Trader

Summary: Turning Claude Fable 5.2 into a 24/7 Stock Trader

This video shows how to turn Claude Fable 5.2 into an automated stock trading bot that runs around the clock. It finds trades, sizes positions, and places orders with stop-losses – even while you sleep.

🛠️ System Setup

  • Broker: Uses Alpaca (paper trading account for testing) connected via API key in a .env file.
  • Rulebook (rules.mmd): Defines risk rules (e.g., max 1 % loss per trade, up to 5 positions, 3 % daily limit) and strategy rules.
  • Command file (claude.md): Instructs Fable to read the rulebook before each trade, place orders as bracket orders (with stop and target), and log all actions.

📈 Strategy Development & Backtesting

Four sources for strategies: personal trades, published strategies, GitHub repos, or Fable's suggestions. Three strategies backtested:

  • Breakout (price closes above 55-day high) → +77 %
  • Pullback (rising stock with sharp dip) → +52 %
  • Oversold bounce (oversold stock) → +72.9 %

Benchmarks: S&P 500 +17.5 %, holding all 30 stocks +112 %. Chosen strategy: Breakout.

🤖 Automation

  • Scanner (cheaper model Sonnet) checks stocks for entry signals regularly.
  • Fable makes final decisions and refines the strategy adaptively.
  • Mode: „alert“ (notification) or „auto“ (fully automatic) – changeable in rulebook.

⏰ 24/7 Operation

Options:

  • Claude Scheduled Tasks (Anthropic cloud, no own computer needed)
  • VPS (e.g., Hostinger) with Claude Code + Telegram webhook
  • Always-on agent like Claude Duet, Grockbot, or Hermes (orchestrator)

📊 Simulation Result

With $10,000 and 75 trades over one year: $11,600 (+16 %) – outperforming S&P 500 (+11 %) and top 30 stocks (+13 %).

The complete setup is available in the free school community.

Bitcoin: Dubious Speculation
2 min read

Bitcoin: Dubious Speculation

📉 Bitcoin: Dubious Speculation – Current Market Analysis

This video provides a detailed analysis of the current Bitcoin market. The speaker shares speculative thoughts on possible price developments and emphasizes the importance of an open, unbiased approach.

🎯 Core Statements & Predictions
  • Current Status: Bitcoin is trading at around $65,000 (as of mid-November).
  • Fake-out at $83,000: After breaking above this level (the previous year's high), a rapid decline followed, typical of such 'fake-outs'.
  • Temporal Proximity to Bear Market End: Many previously optimistic analysts are now becoming pessimistic – a classic sign of market exhaustion in the final stages of a bear market.
  • Possible Scenarios for a Bottom:
    • Scenario 1: Immediate Capitulation – If no recovery occurs, a final capitulation candle with a decline of 30-40% could be imminent within just two weeks.
    • Scenario 2: Rally, then Further Decline – More likely is a short rally until approximately November 21st, followed by another sell-off to the FOMC meeting in December (around December 9th).
🔍 Important Levels & Analogies
  • Realized Price at approximately $54,000: Historically, an important target for Bitcoin bottoms.
  • Comparison to 2015 & 2018/2019: In those years, fake-outs were followed by massive capitulation phases (40-50% decline in two weeks).
  • Pattern of Highs on the 21st: Many local highs in recent months occurred on the 21st of a month – potentially this time as well.
⚠️ Critique of Market Sentiment
  • Emotions and Bias: Many market participants cherry-pick charts that confirm their preconceived notions instead of objectively analyzing data.
  • Lack of Accountability: Few are willing to admit mistakes, which flattens the discussion.
💡 Outlook
  • Mid-December (around December 12th) as a potential timeframe for a final low (FOMC + possible government shutdown).
  • OpenAI IPO next year as a potential catalyst for another downturn (risk of capital rotation).

In summary, the speaker notes that bear markets are hard on all sides and reaffirms his goal of helping people navigate the cycles.

Mushrooms for the Mind & Immune System | Paul Stamets
4 min read

Mushrooms for the Mind & Immune System | Paul Stamets

The Mycelial Network: Earth's Natural Intelligence
  • Paul Stamets introduces mycelium as the immune system and neural network of the forest. A single cubic inch of soil can contain 1 to 8 miles of these fungal networks, setting up the microbiome and enabling ecosystems to thrive.
  • He emphasizes the "entourage effect" — the synergy of hundreds of molecules in whole fungi makes them more effective than isolated pharmaceutical compounds.
Fortifying the Immune System: The Agarikon & Turkey Tail Clinical Trials
  • Detailed results from clinical trials using a mycelial extract of Agarikon and Turkey Tail:
    • Reduced vaccine side effects: Drastically lowered headaches, muscle aches, coughing, and sneezing after mRNA vaccines (key vectors of transmission).
    • Enhanced antibody persistence: A 3x higher antibody count 6 months post-vaccination compared to the placebo group, despite only 4 days of supplementation.
    • Faster recovery: Unvaccinated individuals with COVID recovered 5.1 days sooner than the placebo group (more effective than Tamiflu). The extract decouples reactogenicity from immunogenicity.
  • Stark warning: H5N1 (Bird Flu) has jumped to 90 mammal species with a 40-50% fatality rate in humans. Stamets argues elevating innate immunity is our best defense.
The Psychedelic Revolution: Therapeutics, Neuroplasticity & The Tryptamine Universe
  • Set, Setting, and Integration are critical: Stamets turned down his own father for a session because the mother wasn't participating. Therapy and community support are non-negotiable for safe outcomes.
  • Dosing Protocols:
    • Micro-dosing: Sub-perceptual (~0.1g) for mood, depression, and anxiety relief.
    • Museum dose: A low sensory dose (~0.5g) for enhanced appreciation (art, music).
    • Heroic dose: High doses (5g+), often a single lifetime session for profound trauma resolution.
  • The Stamets Stack: The combination of Psilocybin + Lion's Mane + Niacin. A Nature study showed a 50% increase in finger-tapping speed, indicating powerful neuroplasticity and psychomotor benefits.
  • The Tryptamine Universe: The discovery of tryptophan (the precursor to psilocybin and serotonin) on the Bennu asteroid by NASA leads Stamets to a profound conclusion: the universe is filled with the molecules of consciousness and happiness.
Brain Health & Longevity: Lion's Mane, Cordyceps & Push-ups
  • Lion's Mane: Proven to stimulate NGF (Nerve Growth Factor) and BDNF, promoting neurogenesis. Effects are cumulative over weeks.
  • Cordyceps: Supports cellular energy (ATP) and oxygen utilization (VO2 max), acting as a natural performance adaptogen.
  • Mycoremediation: Highly effective for hydrocarbons (oil spills), but largely impractical for dioxins and plastics in complex ecosystems (the mycelium prefers more nutritious food).
  • Paul's Longevity Protocol:
    • Daily push-ups. He cites a Harvard study showing men who can do 40 push-ups in a single set have a 97% reduced risk of cardiac arrest.
    • Daily supplementation with Agarikon and Turkey Tail to maintain baseline immune readiness, especially before travel or high-exposure events.
Conclusion: A Call for Biological Wisdom
  • Stamets urges the integration of natural intelligence with artificial intelligence. He believes leveraging the complexity of fungi is key to solving our greatest challenges in immunity, mental health, and ecology, advocating for a legacy of creativity and collaboration.